Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.6, 2021 (Journal Indexed in SCI)
Article / Abstract
Title of Journal :
JOURNAL OF CLINICAL ONCOLOGY